Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Back

Become EABM
Become Reviewer

Most Accessed Articles

Multiple Myeloma and the Immune Microenvironment

Volume: 17   Issue: 9
Pp: 806-818
Yawara Kawano, Aldo. M. Roccaro, Irene M. Ghobrial* and Jamil Azzi*
DOI: 10.2174/1568009617666170214102301

C/EBPα Regulates FOXC1 to Modulate Tumor Growth by Interacting with PPARγ in Hepatocellular Carcinoma

Volume: 20   Issue: 1
Pp: 59-66
Zhuo Xu, Shao-Hua Meng, Jian-Guo Bai, Chao Sun*, Li-Li Zhao*, Rui-Feng Tang, Zhao-Lin Yin, Jun-Wei Ji, Wei Yang and Guang-Jun Ma
DOI: 10.2174/1568009619666190912161003

Mechanism and Treatment of Rituximab Resistance in Diffuse Large Bcell Lymphoma

Volume: 19   Issue: 9
Pp: 681-687
Linqing Zou, Guoqi Song, Siyu Gu, Lingling Kong, Shiqi Sun, Li Yang* and William C. Cho*
DOI: 10.2174/1568009619666190126125251

Novel Mechanistic Insights into the Anti-cancer Mode of Arsenic Trioxide

Volume: 20   Issue: 2
Pp: 115-129
Md Wahiduzzaman, Akinobu Ota* and Yoshitaka Hosokawa
DOI: 10.2174/1568009619666191021122006

Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update

Volume: 18   Issue: 9
Pp: 857-868
Shirin Eyvazi, Safar Farajnia*, Siavoush Dastmalchi, Farzad Kanipour, Habib Zarredar and Mojghan Bandehpour
DOI: 10.2174/1568009618666180102102311

PPARγ Agonists in Combination Cancer Therapies

Volume: 20   Issue: 3
Pp: 197-215
Piotr Mrowka and Eliza Glodkowska-Mrowka*
DOI: 10.2174/1568009619666191209102015

CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling

Volume: 20   Issue: 2
Pp: 156-165
Fang Peng, Chuansheng Yang, Yanan Kong, Xiaojia Huang, Yanyu Chen, Yangfan Zhou, Xinhua Xie* and Peng Liu*
DOI: 10.2174/1568009619666191118113220